Loading clinical trials...
Loading clinical trials...
Evaluation of the Effects of Lifebloom One on Physical Activity After Acquired Brain Injury: A Single-Case Experimental Study
The goal of this clinical trial is to evaluate the effects of Lifebloom One in people who have suffered a stroke or a traumatic brain injury. The main questions to be answered are: * Does Lifebloom One allow users to spend more time standing each day? * Does Lifebloom One allow users to improve their balance and gait? Participants will use Lifebloom One during 8 weeks. For each participant, gait and balance are compared either with and without Oxilio or before and after Lifebloom One intervention.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Physical Medicine and Rehabilitation Department - Pitié-Salpêtrière Hospital
Paris, France
Start Date
September 15, 2023
Primary Completion Date
August 29, 2024
Completion Date
August 29, 2024
Last Updated
March 10, 2025
5
ACTUAL participants
Lifebloom One
DEVICE
Lead Sponsor
Lifebloom
Collaborators
NCT05093673
NCT07371455
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06258538